|
|
|
|
LEADER |
00000cz a2200000n 4500 |
001 |
81067520X |
003 |
DE-627 |
005 |
20240319211815.0 |
008 |
141204n||aznnnabbn | aaa |c |
024 |
7 |
|
|a http://d-nb.info/gnd/1063150310
|2 uri
|
035 |
|
|
|a (DE-588)1063150310
|
035 |
|
|
|a (DE-627)81067520X
|
035 |
|
|
|a (DE-576)420528350
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
043 |
|
|
|c XA-DE
|
079 |
|
|
|a g
|b p
|c v
|q f
|v piz
|
100 |
1 |
|
|a Tozan, Yeşim
|
510 |
2 |
|
|0 (DE-627)728664364
|0 (DE-576)372679862
|0 (DE-588)1027243282
|a Universitätsklinikum Heidelberg
|4 affi
|w r
|i Affiliation
|e Affiliation
|9 Z:2010-2016
|
550 |
|
|
|a MSc, MA, PhD
|4 akad
|w r
|i Akademischer Grad
|
550 |
|
|
|0 (DE-627)104544988
|0 (DE-576)208850414
|0 (DE-588)4003157-3
|a Arzt
|4 berc
|w r
|i Charakteristischer Beruf
|
667 |
|
|
|a 16-250
|
678 |
|
|
|b Institut of Public Health, Universitätsklinikum Heidelberg, Research Associate
|
692 |
|
|
|a Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children. - 2014
|
ORI |
|
|
|a WA-MARC-krimdokc001.raw
|
SUB |
|
|
|a KRI
|b 3
|